β-1,4-Gal-T1 Antibodies

Santa Cruz Biotechnology features a diverse variety of β-1,4-Gal-T1 monoclonal antibodies for research focused on understanding this important glycosyltransferase. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). β-1,4-Gal-T1, or β-1,4-galactosyltransferase 1, plays a crucial role in the biosynthesis of glycoproteins and glycolipids, influencing cell-cell interactions and signaling pathways. The enzyme catalyzes essential reactions in the formation of complex carbohydrates, which are vital for various biological processes, including immune response and cellular communication. β-1,4-Gal-T1 activity has been linked to multiple cellular functions and developmental processes. Research has shown that alterations in β-1,4-Gal-T1 expression can impact various pathological conditions, including cancer and congenital disorders. Understanding β-1,4-Gal-T1 function continues to reveal new insights into cellular biology and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of β-1,4-Gal-T1 and its role in health and disease.